Skip to main content
. 2022 Mar 31;12(4):825–834. doi: 10.1007/s13555-022-00711-3

Fig. 1.

Fig. 1

Components for assessing disease severity, including signs and symptoms of AA, impact on quality of life, and treatment history for qualitative evaluation in classification of severity. Questions under each component are attributes for consideration with potential greater implications of severity from top to bottom. AA-IGA Alopecia Areata Investigator Global Assessment, mo months, SALT Severity of Alopecia Tool